Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy

被引：27

作者：

Ishitsuka, Kenji ^{[1
]}

Jimi, Shiro ^{[2
]}

Goldmacher, Victor S. ^{[3
]}

Ab, Olga ^{[3
]}

Tamura, Kazuo ^{[1
]}

机构：

[1] Fukuoka Univ, Div Haematol & Oncol, Dept Internal Med, Fukuoka, Japan

[2] Fukuoka Univ, Cent Lab Pathol & Morphol, Nanakuma Jonan Fukuoka, Japan

[3] ImmunoGen Inc, Cambridge, MA USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 141卷 / 01期

关键词：

natural killer/T cell malignancy; CD56; targeted therapy; IMGN901;

D O I：

10.1111/j.1365-2141.2008.07000.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：129 / 131

页数：4

共 8 条

[1] Phase I study of BB-10901 (huN901-DM1) in patients with relapsed and relapsed/refractory CD56-positive multiple myeloma. [J].

Chanan-Khan, Asher Alban ;

Jagannath, Sundar ;

Schlossman, Robert L. ;

Fram, Robert J. ;

Falzone, Richard M. ;

Roberti, Mary F. ;

Welch, Samantha K. ;

DePaolo, Dawn ;

Anderson, Kenneth C. ;

Munshi, Nikhil C. .

BLOOD, 2006, 108 (11) :1021A-1021A

[2]

GONG JH, 1994, LEUKEMIA, V8, P652

[3] TUMOR INHIBITORS .73. MAYTANSINE, A NOVEL ANTILEUKEMIC ANSA MACROLIDE FROM MAYTENUS-OVATUS [J].

KUPCHAN, SM ;

KOMODA, Y ;

THOMAS, GJ ;

SMITH, RM ;

BRYAN, RF ;

HALTIWAN.RC ;

KARIM, A ;

COURT, WA ;

GILMORE, CJ .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1972, 94 (04) :1354-+

[4] Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study [J].

Lee, J ;

Suh, C ;

Park, YH ;

Ko, YH ;

Bang, SM ;

Lee, JH ;

Lee, DH ;

Huh, J ;

Oh, SY ;

Kwon, HC ;

Kim, HJ ;

Lee, SI ;

Kim, JH ;

Park, J ;

Oh, SJ ;

Kim, K ;

Jung, C ;

Park, K ;

Kim, WS .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) :612-618

[5]

McCann J, 2007, J CLIN ONCOL, V25

[6] NK-cell neoplasms in Japan [J].

Oshimi, K ;

Kawa, K ;

Nakamura, S ;

Suzuki, R ;

Suzumiya, J ;

Yamaguchi, M ;

Kameoka, J ;

Tagawa, S ;

Imamura, N ;

Ohshima, K ;

Kojya, S ;

Iwatsuki, K ;

Tokura, Y ;

Sato, E ;

Sugimori, H .

HEMATOLOGY, 2005, 10 (03) :237-245

[7] In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2′-deacetyl-N2′-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells [J].

Tassone, P ;

Gozzini, A ;

Goldmacher, V ;

Shammas, MA ;

Whiteman, KR ;

Carrasco, DR ;

Li, C ;

Allam, CK ;

Venuta, S ;

Anderson, KC ;

Munshi, NC .

CANCER RESEARCH, 2004, 64 (13) :4629-4636

[8] Structural characterization of the maytansinoid -: monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry [J].

Wang, LT ;

Amphlett, G ;

Blättler, WA ;

Lambert, JM ;

Zhang, W .

PROTEIN SCIENCE, 2005, 14 (09) :2436-2446

← 1 →